Page last updated: 2024-08-18

pyrroles and azd3241

pyrroles has been researched along with azd3241 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, L; Farde, L; Halldin, C; Johnström, P; Malmquist, J; Varnäs, K1
Amini, N; Budd, S; Cselényi, Z; Farde, L; Halldin, C; Helin, S; Johnström, P; Jucaite, A; Kirjavainen, A; Kugler, AR; Minkwitz, M; Posener, JA; Rinne, JO; Svenningsson, P; Varnäs, K; Varrone, A1
Georgievska, B; Kaindlstorfer, C; Kugler, AR; Mather, RJ; Poewe, W; Sommer, P; Stefanova, N; Wenning, GK1
Al-Huniti, N; Li, J; Li, Y; Mullen, JA; Savage, A; Taylor, W; Tong, X; Xu, H; Zhou, D1

Trials

1 trial(s) available for pyrroles and azd3241

ArticleYear
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.
    Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 9

    Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Male; Microglia; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Protein Binding; Pyrimidines; Pyrimidinones; Pyrroles; Receptors, GABA; Severity of Illness Index

2015

Other Studies

3 other study(ies) available for pyrroles and azd3241

ArticleYear
Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:6

    Topics: Animals; Brain; Carbon Radioisotopes; Dose-Response Relationship, Radiation; Female; Humans; Macaca fascicularis; Magnetic Resonance Imaging; Male; Peroxidase; Positron-Emission Tomography; Pyrimidinones; Pyrroles; Radiopharmaceuticals

2015
Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
    Neurotoxicity research, 2015, Volume: 28, Issue:3

    Topics: alpha-Synuclein; Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice, Transgenic; Microglia; Motor Activity; Multiple System Atrophy; Myelin Proteolipid Protein; Neurons; Neuroprotective Agents; Nitro Compounds; Peroxidase; Propionates; Pyrimidinones; Pyrroles; Severity of Illness Index; Treatment Outcome

2015
Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:11

    Topics: Adult; Aged; Bile; Enterohepatic Circulation; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Multiple System Atrophy; Peroxidase; Pyrimidinones; Pyrroles; Random Allocation

2018